(DBXZ) Xtrackers - Xtrackers MSCI - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292097747 • UK Large-Cap Equity

DBXZ: UK Stocks, Equities, ESG, ETF

The Xtrackers MSCI UK ESG UCITS ETF 1D (Ticker: DBXZ) is an exchange-traded fund listed on XETRA, designed to track the performance of the Morningstar UK All Cap TME NR GBP Index. This ETF provides exposure to a broad range of UK equities, focusing on companies with strong environmental, social, and governance (ESG) practices. It is structured as a UCITS-compliant fund, adhering to European regulatory standards for investor protection and transparency. The fund is managed by DWS, a well-established global asset manager.

From a technical perspective, DBXZ has shown a short-term upward trend, with its 20-day moving average (SMA20) at 5.20, slightly above its 50-day moving average (SMA50) at 5.06. However, the 200-day moving average (SMA200) at 4.94 indicates a longer-term downtrend. The Average True Range (ATR) of 0.04 reflects low volatility in recent trading activity. The funds last price of 5.26 suggests moderate price stability, supported by an average daily trading volume of 60,822 shares over the past 20 days.

On the fundamental side, the ETF has assets under management (AUM) of 338.16 million EUR, indicating a significant investor base. The funds ESG focus aligns with growing investor demand for sustainable investments. However, its performance is heavily influenced by broader UK market conditions, including macroeconomic factors and geopolitical developments.

3-Month Forecast: Based on the current technical and fundamental data, DBXZ is expected to experience modest volatility due to its low ATR. The fund may face headwinds from the broader UK equity market, which is sensitive to global economic trends and monetary policy shifts. However, its ESG focus could attract inflows from sustainability-focused investors, potentially supporting its price. Technically, if the SMA20 remains above the SMA50, the fund may maintain its short-term upward momentum, though the longer-term trend remains bearish. Investors should monitor macroeconomic indicators and ESG-related developments for potential impacts on the funds performance.

Additional Sources for DBXZ ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

DBXZ ETF Overview

Market Cap in USD 365m
Category UK Large-Cap Equity
TER 0.18%
IPO / Inception 2007-06-15

DBXZ ETF Ratings

Growth 5y 53.6%
Fundamental -
Dividend 33.6%
Rel. Strength Industry -8.13
Analysts -
Fair Price Momentum 5.08 EUR
Fair Price DCF -

DBXZ Dividends

Dividend Yield 12m 3.49%
Yield on Cost 5y 4.61%
Annual Growth 5y -3.21%
Payout Consistency 81.4%

DBXZ Growth Ratios

Growth Correlation 3m 71.3%
Growth Correlation 12m 86.8%
Growth Correlation 5y 67.9%
CAGR 5y 6.18%
CAGR/Max DD 5y 0.27
Sharpe Ratio 12m 0.96
Alpha 7.99
Beta 0.46
Volatility 15.52%
Current Volume 23.9k
Average Volume 20d 28.7k
What is the price of DBXZ stocks?
As of March 09, 2025, the stock is trading at EUR 5.13 with a total of 23,850 shares traded.
Over the past week, the price has changed by -2.45%, over one month by -0.66%, over three months by +1.58% and over the past year by +17.69%.
Is Xtrackers - Xtrackers MSCI a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Xtrackers - Xtrackers MSCI (XETRA:DBXZ) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.58 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXZ as of March 2025 is 5.08. This means that DBXZ is currently overvalued and has a potential downside of -0.97%.
Is DBXZ a buy, sell or hold?
Xtrackers - Xtrackers MSCI has no consensus analysts rating.
What are the forecast for DBXZ stock price target?
According to ValueRays Forecast Model, DBXZ Xtrackers - Xtrackers MSCI will be worth about 5.7 in March 2026. The stock is currently trading at 5.13. This means that the stock has a potential upside of +10.33%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 5.7 10.3%